448 related articles for article (PubMed ID: 21931078)
1. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure.
van Veldhuisen DJ; Braunschweig F; Conraads V; Ford I; Cowie MR; Jondeau G; Kautzner J; Aguilera RM; Lunati M; Yu CM; Gerritse B; Borggrefe M;
Circulation; 2011 Oct; 124(16):1719-26. PubMed ID: 21931078
[TBL] [Abstract][Full Text] [Related]
2. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.
Small RS; Wickemeyer W; Germany R; Hoppe B; Andrulli J; Brady PA; Labeau M; Koehler J; Sarkar S; Hettrick DA; Tang WH
J Card Fail; 2009 Aug; 15(6):475-81. PubMed ID: 19643357
[TBL] [Abstract][Full Text] [Related]
3. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF).
Braunschweig F; Ford I; Conraads V; Cowie MR; Jondeau G; Kautzner J; Lunati M; Munoz Aguilera R; Man Yu C; Marijianowski M; Borggrefe M; van Veldhuisen DJ;
Eur J Heart Fail; 2008 Sep; 10(9):907-16. PubMed ID: 18715826
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial.
Conraads VM; Tavazzi L; Santini M; Oliva F; Gerritse B; Yu CM; Cowie MR
Eur Heart J; 2011 Sep; 32(18):2266-73. PubMed ID: 21362703
[TBL] [Abstract][Full Text] [Related]
5. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study.
Landolina M; Perego GB; Lunati M; Curnis A; Guenzati G; Vicentini A; Parati G; Borghi G; Zanaboni P; Valsecchi S; Marzegalli M
Circulation; 2012 Jun; 125(24):2985-92. PubMed ID: 22626743
[TBL] [Abstract][Full Text] [Related]
6. Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure.
Catanzariti D; Lunati M; Landolina M; Zanotto G; Lonardi G; Iacopino S; Oliva F; Perego GB; Varbaro A; Denaro A; Valsecchi S; Vergara G;
Pacing Clin Electrophysiol; 2009 Mar; 32(3):363-70. PubMed ID: 19272067
[TBL] [Abstract][Full Text] [Related]
7. Improved algorithm to detect fluid accumulation via intrathoracic impedance monitoring in heart failure patients with implantable devices.
Sarkar S; Hettrick DA; Koehler J; Rogers T; Grinberg Y; Yu CM; Abraham WT; Small R; Tang WH
J Card Fail; 2011 Jul; 17(7):569-76. PubMed ID: 21703529
[TBL] [Abstract][Full Text] [Related]
8. Intrathoracic impedance monitoring to predict decompensated heart failure.
Ypenburg C; Bax JJ; van der Wall EE; Schalij MJ; van Erven L
Am J Cardiol; 2007 Feb; 99(4):554-7. PubMed ID: 17293202
[TBL] [Abstract][Full Text] [Related]
9. OptiVol fluid status monitoring with an implantable cardiac device: a heart failure management system.
Yamokoski LM; Haas GJ; Gans B; Abraham WT
Expert Rev Med Devices; 2007 Nov; 4(6):775-80. PubMed ID: 18035943
[TBL] [Abstract][Full Text] [Related]
10. Rationale and design of a prospective trial to assess the sensitivity and positive predictive value of implantable intrathoracic impedance monitoring in the prediction of heart failure hospitalizations: the SENSE-HF study.
Cowie MR; Conraads V; Tavazzi L; Yu CM;
J Card Fail; 2009 Jun; 15(5):394-400. PubMed ID: 19477399
[TBL] [Abstract][Full Text] [Related]
11. Single center experience with intrathoracic impedance monitoring.
Qiao Q; Hua W; Ding LG; Chen KP; Wang J; Wang FZ; Zhang S
Chin Med J (Engl); 2011 Jul; 124(14):2219-21. PubMed ID: 21933630
[TBL] [Abstract][Full Text] [Related]
12. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization.
Yu CM; Wang L; Chau E; Chan RH; Kong SL; Tang MO; Christensen J; Stadler RW; Lau CP
Circulation; 2005 Aug; 112(6):841-8. PubMed ID: 16061743
[TBL] [Abstract][Full Text] [Related]
13. Device monitoring of intrathoracic impedance: clinical observations from a patient registry.
Andriulli J
Am J Cardiol; 2007 May; 99(10A):23G-8G. PubMed ID: 17512419
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure.
Vollmann D; Nägele H; Schauerte P; Wiegand U; Butter C; Zanotto G; Quesada A; Guthmann A; Hill MR; Lamp B;
Eur Heart J; 2007 Aug; 28(15):1835-40. PubMed ID: 17309902
[TBL] [Abstract][Full Text] [Related]
15. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.
Whellan DJ; Ousdigian KT; Al-Khatib SM; Pu W; Sarkar S; Porter CB; Pavri BB; O'Connor CM;
J Am Coll Cardiol; 2010 Apr; 55(17):1803-10. PubMed ID: 20413029
[TBL] [Abstract][Full Text] [Related]
16. The lung impedance monitoring in treatment of chronic heart failure (the LIMIT-CHF study).
Domenichini G; Rahneva T; Diab IG; Dhillon OS; Campbell NG; Finlay MC; Baker V; Hunter RJ; Earley MJ; Schilling RJ
Europace; 2016 Mar; 18(3):428-35. PubMed ID: 26683599
[TBL] [Abstract][Full Text] [Related]
17. Device monitoring of heart failure in cardiac resynchronization therapy device recipients: a single-center experience with a novel multivector impedance monitoring system.
Forleo GB; Panattoni G; Schirripa V; Papavasileiou LP; Della Rocca DG; Politano A; Ticconi F; Biscione C; Sergi D; Di Molfetta A; Santini L; Capria A; Romeo F
J Cardiovasc Med (Hagerstown); 2013 Oct; 14(10):726-32. PubMed ID: 23996011
[TBL] [Abstract][Full Text] [Related]
18. Impact of cardiac resynchronization therapy on hospitalizations in the Resynchronization-Defibrillation for Ambulatory Heart Failure trial.
Gillis AM; Kerr CR; Philippon F; Newton G; Talajic M; Froeschl M; Froeschl S; Swiggum E; Yetisir E; Wells GA; Tang AS
Circulation; 2014 May; 129(20):2021-30. PubMed ID: 24610807
[TBL] [Abstract][Full Text] [Related]
19. Decreased Intrathoracic Impedance Associated With OptiVol Alert Can Diagnose Increased B-Type Natriuretic Peptide - MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) Study - .
Nishii N; Kubo M; Okamoto Y; Fujii S; Watanabe A; Toyama Y; Yamada T; Doi M; Morita H; Ito H;
Circ J; 2015; 79(6):1315-22. PubMed ID: 25787230
[TBL] [Abstract][Full Text] [Related]
20. Fundamentals of intrathoracic impedance monitoring in heart failure.
Wang L
Am J Cardiol; 2007 May; 99(10A):3G-10G. PubMed ID: 17512421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
